DIOVAN-HCT 12.5 MG — DIN 02308908
HYDROCHLOROTHIAZIDE : 12.5 MG VALSARTAN : 320 MG · NOVARTIS PHARMACEUTICALS CANADA INC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is DIOVAN-HCT?
DIOVAN-HCT 12.5 MG contains HYDROCHLOROTHIAZIDE : 12.5 MG VALSARTAN : 320 MG. It is listed in the Health Canada Drug Product Database under DIN 02308908, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 12-May-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DIOVAN-HCT used for?
DIOVAN-HCT (valsartan and hydrochlorothiazide tablets) is indicated for the treatment of mild to moderate essential hypertension in patients for whom combination therapy is appropriate. DIOVAN-HCT is not indicated for initial therapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Valsartan And Diuretics cost around the world?
Valsartan And Diuretics is listed on 21 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Spain | PVP con IVA (public price) | 221 | 234 | EUR███.██ |
| Saudi Arabia | public | 87 | 134 | SAR███.██ |
| South Africa | single exit price | 72 | 75 | ZAR███.██ |
| United States | acquisition | 4 | 68 | USD███.██ |
| Norway | max AUP (pharmacy retail) | 9 | 58 | NOK███.██ |
| Italy | prezzo al pubblico (classe A) | 22 | 51 | EUR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 46 | 47 | EUR███.██ |
| Bahrain | retail (max) | 20 | 45 | BHD███.██ |
| Sweden | AIP (pharmacy purchase price) | 12 | 42 | SEK███.██ |
| Czechia | max producer price (ex-factory) | 8 | 35 | CZK███.██ |
| Australia | ex-manufacturer | 12 | 34 | AUD███.██ |
| Belgium | public | 33 | 33 | EUR███.██ |
| Greece | producer price (ex-factory) | 25 | 25 | EUR███.██ |
| United Arab Emirates | public | 17 | 17 | AED███.██ |
| Luxembourg | reimbursement | 15 | 15 | EUR███.██ |
| Hungary | producer price (ex-factory) | 12 | 14 | HUF███.██ |
| Slovakia | categorised final price | 7 | 11 | EUR███.██ |
| Morocco | PPV (public price) | 3 | 9 | MAD███.██ |
| Iceland | max wholesale | 4 | 8 | ISK███.██ |
| Romania | max producer price | 4 | 8 | RON███.██ |
| United Kingdom | hospital | 3 | 3 | GBP███.██ |
966 pack listings across 636 brand entries and 18 price bases, refreshed 08 Sep 2026. Ranges span every Valsartan And Diuretics pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Valsartan And Diuretics in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
12 holders have a Canadian DIN containing Valsartan And Diuretics, across 63 DINs, of which 32 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 8 | 5 | NOVO-VALSARTAN/HCTZ, TEVA-VALSARTAN/HCTZ | Sourceable in Canada |
| AURO PHARMA INC | 5 | 5 | AURO-VALSARTAN HCT | Sourceable in Canada |
| NOVARTIS PHARMACEUTICALS CANADA INC | 5 | 5 | DIOVAN-HCT | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 5 | 5 | SANDOZ VALSARTAN HCT | Sourceable in Canada |
| SANIS HEALTH INC | 5 | 5 | VALSARTAN HCT | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 5 | 4 | VALSARTAN HCT | Sourceable in Canada |
| PRO DOC LIMITEE | 5 | 3 | VALSARTAN-HCTZ | Sourceable in Canada |
| APOTEX INC | 5 | 0 | APO-VALSARTAN/HCTZ | No marketed DIN |
| AVANSTRA INC | 5 | 0 | AVA-VALSARTAN HCT | No marketed DIN |
| MYLAN PHARMACEUTICALS ULC | 5 | 0 | MYLAN-VALSARTAN HCTZ | No marketed DIN |
| PHARMASCIENCE INC | 5 | 0 | PMS-VALSARTAN-HCTZ | No marketed DIN |
| QD PHARMACEUTICALS ULC | 5 | 0 | Q-VALSARTAN HCTZ | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 12.5 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | 2 blister strips of 14 tablets |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Valsartan And Diuretics |
|---|---|
| ATC code | C09DA03 |
| AHFS class | 56:22.20 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02308908 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2308908 |
| Brand name | DIOVAN-HCT |
| Generic / active ingredient | HYDROCHLOROTHIAZIDE : 12.5 MG VALSARTAN : 320 MG |
| Market authorization holder | NOVARTIS PHARMACEUTICALS CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | C09DA03 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C09DA |
| Current status | MARKETED |
| Status date | 12-May-2008 |
| Original market date | 2009-02-20 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
32 of 63 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-VALSARTAN HCT | 80 MG | TABLET | AURO PHARMA INC | MARKETED | 02408112 |
| AURO-VALSARTAN HCT | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | 02408147 |
| AURO-VALSARTAN HCT | 12.5 MG | TABLET | AURO PHARMA INC | MARKETED | 02408120 |
| AURO-VALSARTAN HCT | 25 MG | TABLET | AURO PHARMA INC | MARKETED | 02408139 |
| AURO-VALSARTAN HCT | 320 MG | TABLET | AURO PHARMA INC | MARKETED | 02408155 |
| DIOVAN-HCT | 25 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | 02246955 |
| DIOVAN-HCT | 160 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | 02241901 |
| DIOVAN-HCT | 12.5 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | 02241900 |
| DIOVAN-HCT | 25 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | 02308916 |
| SANDOZ VALSARTAN HCT | 320 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | 02356724 |
2 · Same class — other molecules in ATC C09DA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Valsartan And Diuretics | APO-VALSARTAN/HCTZ · AURO-VALSARTAN HCT · AVA-VALSARTAN HCT · DIOVAN-HCT · MYLAN-VALSARTAN HCTZ · NOVO-VALSARTAN/HCTZ · PMS-VALSARTAN-HCTZ · Q-VALSARTAN HCTZ · SANDOZ VALSARTAN HCT · TEVA-VALSARTAN/HCTZ · VALSARTAN HCT · VALSARTAN-HCTZ | 63 | 32 | Yes |
| Candersartan And Diuretics | ACCEL-CANDESARTAN/HCTZ · ACT CANDESARTAN/HCT · AG-CANDESARTAN HCT · APO-CANDESARTAN/HCTZ · ATACAND PLUS · AURO-CANDESARTAN HCT · CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE · CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS · CANDESARTAN HCT · CANDESARTAN-HCTZ · CANDESARTAN/HCTZ · JAMP CANDESARTAN-HCT · MAR-CANDESARTAN / HCTZ · MYLAN-CANDESARTAN HCTZ · NRA-CANDESARTAN HCTZ · PMS-CANDESARTAN-HCTZ · SANDOZ CANDESARTAN PLUS · SEPTA-CANDESARTAN HCTZ · TEVA-CANDESARTAN/HCTZ · ZINDA-CANDESARTAN/HYDROCHLOROTHIAZIDE | 49 | 22 | Yes |
| Telmisartan And Diuretics | ACH-TELMISARTAN HCTZ · ACT TELMISARTAN/HCT · AG TELMISARTAN-HCT · ALEMBIC-TELMISARTAN/HCTZ · APO-TELMISARTAN/HCTZ · AURO-TELMISARTAN HCTZ · JAMP TELMISARTAN-HCT · MICARDIS PLUS · MYLAN-TELMISARTAN HCTZ · NRA-TELMISARTAN/HCTZ · NTP-TELMISARTAN HCTZ · PENDO-TELMISARTAN-HCTZ · PMS-TELMISARTAN-HCTZ · PRO-TELMISARTAN-HCTZ · SANDOZ TELMISARTAN HCT · TARO-TELMISARTAN HCTZ · TELMISARTAN HCTZ · TELMISARTAN-HCTZ · TELMISARTAN/HCTZ · TEVA-TELMISARTAN HCTZ · VAN-TELMISARTAN-HCTZ | 42 | 22 | Yes |
| Losartan And Diuretics | ACT LOSARTAN/HCT · AG-LOSARTAN HCTZ · APO-LOSARTAN/HCTZ · AURO-LOSARTAN HCT · HYZAAR · HYZAAR DS · JAMP-LOSARTAN HCTZ · LOSARTAN HCT · LOSARTAN HCT DS · LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE · LOSARTAN-HCTZ · LOSARTAN/HCT · LOSARTAN/HCTZ · MINT-LOSARTAN/HCTZ · MINT-LOSARTAN/HCTZ DS · MYLAN-LOSARTAN HCTZ · PMS-LOSARTAN-HCTZ · RATIO-LOSARTAN HCTZ · SANDOZ LOSARTAN HCT · SANDOZ LOSARTAN HCT DS · SEPTA-LOSARTAN HCTZ · TEVA-LOSARTAN/HCTZ · VAN-LOSARTAN-HCTZ | 53 | 21 | Yes |
| Olmesartan Medoxomil And Diuretics | ACH-OLMESARTAN HCTZ · AG-OLMESARTAN HCTZ · APO-OLMESARTAN/HCTZ · AURO-OLMESARTAN HCTZ · GLN-OLMESARTAN HCTZ · JAMP-OLMESARTAN HCTZ · NRA-OLMESARTAN HCTZ · OLMESARTAN MEDOXOMIL / HYDROCHLOROTHIAZIDE · OLMESARTAN/HCTZ · OLMETEC PLUS · PMS-OLMESARTAN-HCTZ · PRZ-OLMESARTAN/HCTZ · SANDOZ OLMESARTAN HCTZ · TEVA-OLMESARTAN / HCTZ · TEVA-OLMESARTAN/HCTZ | 45 | 21 | Yes |
| Irbesartan And Diuretics | ACT IRBESARTAN/HCT · AG-IRBESARTAN HCTZ · APO-IRBESARTAN/HCTZ · AURO-IRBESARTAN HCT · AVA-IRBESARTAN/HCTZ · AVALIDE · DOM-IRBESARTAN-HCTZ · IRBESARTAN AND HYDROCHLOROTHIAZIDE · IRBESARTAN HCT · IRBESARTAN-HCTZ · IRBESARTAN/HCT · IRBESARTAN/HCTZ · JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE · MINT-IRBESARTAN/HCTZ · MYLAN-IRBESARTAN HCTZ · NTP-IRBESARTAN/HCTZ · PENDO-IRBESARTAN-HCTZ · PMS-IRBESARTAN-HCTZ · RAN-IRBESARTAN HCTZ · SANDOZ IRBESARTAN HCT · TEVA-IRBESARTAN HCTZ · TEVA-IRBESARTAN/HCTZ · VAN-IRBESARTAN-HCTZ | 67 | 17 | Yes |
| Azilsartant Medoximil And Diuretics | EDARBYCLOR | 3 | 2 | Yes |
| Eprosartan And Diuretics | TEVETEN PLUS | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C09D
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C09DB | Telmisartan And Amlodipine | 12 | 8 |
| C09DX | Valsartan And Sacubitril | 6 | 6 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is DIOVAN-HCT called?
The same molecule, Valsartan And Diuretics, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Diovan | Latin | Australia, Bahrain, Iceland, Norway, South Africa |
| Valsartan Krka | Latin | Iceland, Norway, Sweden |
| Valsartan Sandoz | Latin | Norway, Sweden |
| Valsartan/Hydrochlorothiazide Krka | Latin | Norway, Sweden |
| VALSACOMBI | Latin | Czechia |
| Valsartan/Hydrochlorothiazide Sandoz | Latin | Norway, Sweden |
| Diovan Comp | Latin | Norway |
| Valsartan Actavis | Latin | Norway, Sweden |
| CO-TABUVAN | Latin | Bahrain, Saudi Arabia |
| Dilart | Latin | Australia |
| Valsartan/Hydrochlorthiazid Actavis | Latin | Norway |
| ARBAVAL PLUS | Latin | Bahrain, Saudi Arabia |
| ARBITEN PLUS | Latin | Bahrain, Saudi Arabia |
| BLESSIN | Latin | Czechia |
| CO-ANGINET | Latin | Bahrain, Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.